Catalysts for Alembic Pharmaceuticals Inc
165 tracked
Dec 17, 2021
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→
Dec 17, 2021
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→
Sep 3, 2021
approval
METRONIDAZOLE — FDA approval
METRONIDAZOLE
→
Jul 7, 2021
approval
DESIPRAMINE HYDROCHLORIDE — FDA approval
DESIPRAMINE HYDROCHLORIDE
→
Jun 4, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jun 4, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
May 14, 2021
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Jun 17, 2020
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Feb 24, 2020
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Jan 15, 2020
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Jan 15, 2020
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Jan 15, 2020
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Jan 13, 2020
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
TIZANIDINE HYDROCHLORIDE
→
Dec 17, 2019
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Dec 17, 2019
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Dec 17, 2019
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Oct 9, 2019
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Sep 19, 2019
approval
FENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approval
choline fenofibrate
→
Sep 19, 2019
approval
FENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approval
choline fenofibrate
→
Sep 19, 2019
approval
FENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approval
choline fenofibrate
→
Aug 14, 2019
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Jul 5, 2019
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Apr 25, 2019
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Apr 25, 2019
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Oct 18, 2018
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Jun 8, 2018
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
May 1, 2018
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Dec 29, 2017
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Dec 29, 2017
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Dec 29, 2017
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→